DCF — LAKELAND REGIONAL MED CTR
Enterprise Value: $220.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$220.4M
Enterprise Value
$41.0M
PV of Cash Flows
$179.4M
PV of Terminal Value
$288.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $955.9M | $44.7M | 5.0% | $-0.9M | $-0.8M |
| Year 2 | $984.5M | $55.9M | 6.0% | $6.4M | $5.3M |
| Year 3 | $1.0B | $67.7M | 7.0% | $14.2M | $10.7M |
| Year 4 | $1.0B | $75.0M | 7.0% | $18.6M | $12.7M |
| Year 5 | $1.1B | $79.9M | 7.0% | $21.1M | $13.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $220.4M. Terminal value accounts for 81% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$928.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.04180900911706749
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5